Ixico (IXI)


Latest News

IXICO sees robust revenue growth

IXICO saw robust revenue growth in the year to the end of September strengthened by the entry into a number of new co...

Final Results

Announcement of full year/4th quarter financial results

Strategic and Operational Update

IXICO wins contract to deploy biosensors in clinical trial

IXICO has signed a new contract with another leading biopharmaceutical company to support the use of wrist worn activ...

All News

11-12-17IXICO sees robust revenue growth StockMarketWire
11-12-17Final ResultsRNS
28-11-17Strategic and Operational UpdateRNS
16-11-17IXICO wins contract to deploy biosensors in clinical trial StockMarketWire
16-11-17Contract to Deploy Biosensors in Clinical TrialRNS
19-10-17IXICO set to exceed expectationsStockMarketWire
19-10-17Trading StatementRNS
04-10-17IXICO wins new contract to support clinical trialStockMarketWire
04-10-17New contract to support Phase II clinical trialRNS
28-09-17New contract in Huntington's diseaseRNS
25-09-17IXICO wins contract with biopharmaceutical companyStockMarketWire
25-09-17New Contract with Biopharmaceutical CompanyRNS
05-09-17IXICO five-year contract extended StockMarketWire
05-09-17Extension of a 5 year contractRNS
08-08-17Director/PDMR ShareholdingRNS
24-07-17IXICO expands collaboration with BiogenStockMarketWire
24-07-17Expansion of Collaboration with BiogenRNS
18-07-17IXICO hosts Alzheimer expert symposiumStockMarketWire
18-07-17IXICO hosts Alzheimer Expert SymposiumRNS
05-07-17FTSE rises as GBP dips ahead of UK services PMIStockMarketWire
05-07-17IXICO wins contract for imaging clinical trial servicesStockMarketWire
05-07-17New contract for imaging clinical trial servicesRNS
22-05-17IXICO losses narrow StockMarketWire
22-05-17Half Yearly Report to 31 March 2017RNS
16-05-17Notice of H1 ResultsRNS
12-04-17Exercise of share optionsRNS
29-03-17Director/PDMR ShareholdingRNS
29-03-17Director/PDMR ShareholdingRNS
29-03-17Exercise of Share OptionsRNS
13-03-17IXICO wins $1.5m contractStockMarketWire
13-03-17IXICO signs US$1.5m contractRNS
10-03-17IXICO to present at workshop in ArizonaStockMarketWire
10-03-17To present novel sleep measurement technologyRNS
09-02-17Grant of Share OptionsRNS
30-01-17Result of AGMRNS
17-01-17Director/PDMR ShareholdingRNS
17-01-17IXICO appoints CEOStockMarketWire
17-01-17Appointment of Giulio Cerroni as CEORNS
16-01-17Annual Report and Accounts and Notice of AGMRNS
13-01-17Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:IXI Editorial
  • Regulatory news feed for LSE:IXI Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account